These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 7587232

  • 1. Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.
    Despotis GJ, Hogue CW, Santoro SA, Joist JH, Barnes PW, Lappas DG.
    Crit Care Med; 1995 Oct; 23(10):1674-9. PubMed ID: 7587232
    [Abstract] [Full Text] [Related]

  • 2. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R, Jacobs C.
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [Abstract] [Full Text] [Related]

  • 3. Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.
    Schroeder AP, Knudsen LL, Husted SE, Knudsen L, Ingerslev J.
    J Thromb Thrombolysis; 2001 Oct; 12(2):157-63. PubMed ID: 11729367
    [Abstract] [Full Text] [Related]

  • 4. In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients.
    Despotis GJ, Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Zimmermann JJ, Lappas DG.
    Anesth Analg; 1994 Oct; 79(4):670-4. PubMed ID: 7943773
    [Abstract] [Full Text] [Related]

  • 5. In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation.
    Linkins LA, Julian JA, Rischke J, Hirsh J, Weitz JI.
    Thromb Res; 2002 Sep 01; 107(5):241-4. PubMed ID: 12479885
    [Abstract] [Full Text] [Related]

  • 6. Effect of clot-detection methods and reagents on activated partial thromboplastin time (APTT). Implications in heparin monitoring by APTT.
    D'Angelo A, Seveso MP, D'Angelo SV, Gilardoni F, Dettori AG, Bonini P.
    Am J Clin Pathol; 1990 Sep 01; 94(3):297-306. PubMed ID: 2396604
    [Abstract] [Full Text] [Related]

  • 7. An ex vivo comparison of partial thromboplastin time and activated clotting time for heparin anticoagulation in an ovine model.
    Berk ZBK, Shah A, Sun W, Griffith BP, Wu ZJ.
    Artif Organs; 2022 Mar 01; 46(3):501-505. PubMed ID: 34698388
    [Abstract] [Full Text] [Related]

  • 8. Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration.
    Koerber JM, Smythe MA, Begle RL, Mattson JC, Kershaw BP, Westley SJ.
    Pharmacotherapy; 1999 Aug 01; 19(8):922-31. PubMed ID: 10453963
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and pharmacodynamics of a therapeutic dose of unfractionated heparin (200 U/kg) administered subcutaneously or intravenously to healthy dogs.
    Diquélou A, Barbaste C, Gabaig AM, Trumel C, Abella-Bourges N, Guelfi JF, Bousquet Mélou A.
    Vet Clin Pathol; 2005 Sep 01; 34(3):237-42. PubMed ID: 16134071
    [Abstract] [Full Text] [Related]

  • 10. Correlation between activated clotting time and activated partial thromboplastin times.
    Smythe MA, Koerber JM, Nowak SN, Mattson JC, Begle RL, Westley SJ, Balasubramaniam M.
    Ann Pharmacother; 2002 Jan 01; 36(1):7-11. PubMed ID: 11816262
    [Abstract] [Full Text] [Related]

  • 11. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
    Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Barnes P, Cox JL, Lappas DG.
    Anesthesiology; 1994 Feb 01; 80(2):338-51. PubMed ID: 8311316
    [Abstract] [Full Text] [Related]

  • 12. The APTT response of pregnant plasma to unfractionated heparin.
    Chunilal SD, Young E, Johnston MA, Robertson C, Naguit I, Stevens P, Galashan D, Oskamp ML, Brennan B, Ginsberg JS.
    Thromb Haemost; 2002 Jan 01; 87(1):92-7. PubMed ID: 11848463
    [Abstract] [Full Text] [Related]

  • 13. Two instruments to determine activated partial thromboplastin time: implications for heparin monitoring.
    Taylor CT, Petros WP, Ortel TL.
    Pharmacotherapy; 1999 Apr 01; 19(4):383-7. PubMed ID: 10212007
    [Abstract] [Full Text] [Related]

  • 14. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA, Monitz HG, Fernandez JD, Fazlollah TM, Knezevic A, Miller BE.
    Anesth Analg; 2010 Jul 01; 111(1):173-9. PubMed ID: 20519414
    [Abstract] [Full Text] [Related]

  • 15. Variation among commercial activated partial thromboplastin time reagents in response to heparin.
    Shapiro GA, Huntzinger SW, Wilson JE.
    Am J Clin Pathol; 1977 May 01; 67(5):477-80. PubMed ID: 857645
    [Abstract] [Full Text] [Related]

  • 16. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R, Marwaha G, Sinha P, Quantz M, Stitt L, Gao R, Subramanian S, Schaus M, Keeney M, Chin-Yee I, Murkin J.
    Can J Anaesth; 2009 Jul 01; 56(7):489-96. PubMed ID: 19408066
    [Abstract] [Full Text] [Related]

  • 17. The diagnostic accuracy of bedside and laboratory coagulation: procedures used to monitor the anticoagulation status of patients treated with heparin.
    Solomon HM, Mullins RE, Lyden P, Thompson P, Hudoff S.
    Am J Clin Pathol; 1998 Apr 01; 109(4):371-8. PubMed ID: 9535388
    [Abstract] [Full Text] [Related]

  • 18. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW, Strebus AF, Meinders AE, Briët E.
    Haemostasis; 1996 Apr 01; 26(2):85-9. PubMed ID: 9119287
    [Abstract] [Full Text] [Related]

  • 19. The activated partial thromboplastin time as a monitor of heparin therapy: a warning.
    Makary AZ, Waterbury L.
    Johns Hopkins Med J; 1977 Jun 01; 140(6):311-5. PubMed ID: 864903
    [Abstract] [Full Text] [Related]

  • 20. Lack of in vitro interaction between heparin and nitroglycerin.
    Barnes AD, Horn JR, Wittkowsky AK.
    Am J Clin Pathol; 1996 Mar 01; 105(3):298-300. PubMed ID: 8602610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.